Dynamic coagulofibrinolytic responses under long-term VV-ECMO management without anticoagulation in a COVID-19-ARDS patient: A case report

Venovenous extracorporeal membrane oxygenation (ECMO) is recommended for the treatment of critically ill patients with acute respiratory distress syndrome due to coronavirus disease 2019 (COVID-19). However, ECMO management can cause both bleeding and thrombotic complications. There are insufficient...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2023-01, Vol.102 (4), p.e32817-e32817
Hauptverfasser:	Matsumoto, Hironori, Kikuchi, Satoshi, Murata, Satoru, Ohshita, Muneaki, Harima, Yutaka, Annen, Suguru, Mukai, Naoki, Nakabayashi, Yuki, Ogawa, Shirou, Okita, Mitsuo, Takeba, Jun, Sato, Norio
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Clinical Case Report COVID-19 - complications COVID-19 - therapy Extracorporeal Membrane Oxygenation - adverse effects Fibrin Fibrinogen Degradation Products Hemorrhage - etiology Hemostatics Heparin Humans Male Middle Aged Respiratory Distress Syndrome - etiology Respiratory Distress Syndrome - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!